Paulson & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-90,000
Closed -$7.85M 71
2017
Q2
$7.85M Buy
+90,000
New +$7.61M 0.11% 67
2017
Q1
Sell
-111,600
Closed -$8.26M 107
2016
Q4
$8.26M Sell
111,600
-50,900
-31% -$3.81M 0.1% 70
2016
Q3
$12.3M Buy
+162,500
New +$12.4M 0.13% 55
2015
Q4
Sell
-4,711,900
Closed -$365M 78
2015
Q3
$365M Hold
4,711,900
1.89% 15
2015
Q2
$427M Hold
4,711,900
1.97% 14
2015
Q1
$354M Hold
4,711,900
1.8% 18
2014
Q4
$346M Sell
4,711,900
-1,357,700
-22% -$95.4M 1.79% 20
2014
Q3
$428M Buy
6,069,600
+2,666,981
+78% +$176M 1.78% 21
2014
Q2
$192M Hold
3,402,619
0.83% 36
2014
Q1
$179M Sell
3,402,619
-1,300
-0% -$64.7K 0.87% 35
2013
Q4
$162M Hold
3,403,919
0.8% 34
2013
Q3
$146M Hold
3,403,919
0.94% 33
2013
Q2
$123M Buy
+3,403,919
New +$132M 0.87% 31

Other funds holding HCA

Paulson & Co's HCA Position: Q3 2017 in Review

Paulson & Co sold out of HCA Healthcare (HCA) in Q3 2017, closing a stake of 90,000 shares — an estimated $7.85M sold.

Paulson & Co first reported a position in HCA in Q2 2013 and held it in 13 quarters. The position peaked at $428M in Q3 2014. 529 funds tracked by Wall St. Rank hold HCA as of Q3 2017.

  • Paulson & Co reported no remaining HCA Healthcare position as of Q3 2017 after selling out during the quarter.
  • Paulson & Co sold 90,000 HCA Healthcare shares in Q3 2017, an estimated $7.85M.
  • Paulson & Co first reported a position in HCA Healthcare in Q2 2013 and held it in 13 quarters.
  • Paulson & Co's HCA Healthcare position peaked at $428M in Q3 2014.
  • 529 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.